needle single News
-
Showcase
Zeneo® Adrenaline: A New Innovative Formulation
Anaphylactic shock is an absolute medical emergency. When anaphylactic shock is suspected, emergency services must be called and emergency first aid administered immediately. The only first-line treatment for anaphylactic shock is injectable adrenaline1. In the USA: 1.6% to 5.1% of the population has experienced anaphylactic shock, 1% of hospitalizations are caused by it, 0.1% of patients ...
By Crossject
-
New Multi-pronged Injection Needle Receives CE Mark Approval/ 510k Exempt Status (U.S.)
Conshohocken, PA., September 30, 2003-Rex Medical, L.P., today announced the 510K Exempt Status (U.S.) and CE Mark Approval to market the Quadra-Fuse™ Multi-Pronged Injection Needle designed for the infusion of fluids (chemicals, hypertonic saline, etc.) into soft tissue (liver, other organs, etc.). Quadra-Fuse™ technology is an 18 Gauge stainless steel, multi-pronged ...
-
The Aesthetic Guide / March-April 2022
Agnes RF is an innovative radiofrequency microneedling device focused on selective electro-coagulation to rejuvenate facial skin and sculpt fat. Pioneered by a group of dermatologists, the Agnes RF microneedling device utilizes an exclusive Square Wave RF energy to focus on gentle yet effective procedures while ensuring patient safety. Agne RF has exclusive single and three-pin needles designed ...
-
Meissa Announces IND Clearance for Phase 1 Study of COVID-19 Intranasal Live Attenuated Vaccine
Initial preclinical data shows MV-014-212 induced a SARS-CoV-2-specific mucosal IgA response, generated serum neutralizing antibodies, and provided efficacy against challenge REDWOOD CITY, Calif., March 16, 2021 – Meissa Vaccines (“Meissa”), a biotechnology company developing vaccines to prevent serious viral respiratory infections, announced today that the company has ...
-
Preclinical Data on Intranasal COVID-19 Vaccine Shows Protection from SARS-CoV-2 after Single Dose
? Meissa’s intranasal recombinant live attenuated COVID-19 vaccine, MV-014-212, induced mucosal as well as systemic antibodies against SARS-CoV-2 and two variants of concern ? MV-014-212 was built on the company’s AttenuBlock platform and is designed to be appropriately attenuated, genetically stable, and optimized to drive robust, broad, and durable immunity ? Data will be ...
-
YourBio Health launches nearly painless, at-home COVID-19 antibody test
YourBio Health, formerly Seventh Sense Biosystems, Inc., developers of the world’s first push-button blood collection device, announced the launch of its website where UK consumers can order a convenient, easy to use, nearly painless and accurate COVID-19 antibody test. “We’re happy to launch our COVID-19 antibody test service to UK consumers today,” said Stephen Hahn, ...
-
Meissa Vaccines Provides a Pipeline Update on Vaccine Candidates for COVID-19 and RSV
Meissa’s COVID-19 vaccine candidate, MV-014-210, is designed to be delivered as a single, intranasal, adjuvant-free dose, that is economical and can be rapidly scaled to supply global demands Preliminary clinical data show MV-012-968, the company’s vaccine candidate for respiratory syncytial virus, is heavily attenuated and induces a RSV-specific mucosal IgA response in the ...
-
Meissa Vaccines Begins Study of RSV Vaccine Candidate in Seronegative Children
· No vaccine is currently approved to protect against respiratory syncytial virus (RSV) · RSV is the leading cause of infant hospitalization in the United States and is considered the “missing” pediatric vaccine · Previous clinical data in seropositive adult and pediatric participants showed MV-012-968 was well-tolerated, appropriately attenuated, and stimulated ...
-
Meissa Announces 1st Dosing in Phase 2 Study of Intranasal Live Attenuated Vaccine Candidate for RSV
- The randomized, double-blind, placebo-controlled challenge study is designed to evaluate safety and prophylactic efficacy of MV-012-968 against symptomatic respiratory syncytial virus (RSV) - Previous clinical data shows MV-012-968 is well-tolerated, heavily attenuated, and induces an RSV-specific mucosal IgA response in healthy seropositive adults and pediatric participants REDWOOD ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you